We develop, manufacture, and deliver protective and life-saving solutions for communities around the world.
Opioid Emergency Preparedness
Emergent distributes NARCAN® Nasal Spray 4 mg and KLOXXADO® (naloxone HCI) Nasal Spray 8 mg to federal and state leaders, community-based organizations, harm reduction groups, law enforcement and first responders through its expansive distribution network.
NARCAN® Nasal Spray is also widely available nationwide as the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose.
KLOXXADO®* Nasal Spray 8 mg
(naloxone HCl)
Contact Information for Opioid Emergency Preparedness Products:
Medical Countermeasures
For over 25 years, Emergent has been at the forefront of preparedness, working hand in hand with governments and agencies to deliver products that protect against some of the world’s most pressing health threats, including botulism, Ebola, smallpox, mpox and anthrax.
ACAM2000®
(Smallpox and Mpox (Vaccinia) Vaccine, Live)
ACAM2000®
(Smallpox (Vaccinia) Vaccine, Live)
ANTHRASIL®
[Anthrax Immune Globulin Intravenous (Human)]
BAT®
[Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)]
BioThrax®
(Anthrax Vaccine Adsorbed)
CNJ-016®
(vaccinia immune globulin intravenous, human)
CYFENDUS®
(Anthrax Vaccine Adsorbed, Adjuvanted)
Ebanga™*
(ansuvimab-zykl)
raxibacumab injection
A fully human monoclonal antibody
TEMBEXA®
(brincidofovir)
Contact Information for Medical Countermeasures Products:
Effect or Product ComplaintContact Customer ServiceSubmit Medical
Information RequestIndividual Named Patient
Use Request Form*
*Individual Named Patient Use may be a potential pathway for a healthcare provider treating an individual patient with an immediately life-threatening condition to gain access to an Emergent product for treatment outside of commercially available means.
*EbangaTM is a trademark of RIDGEBACK BIOTHERAPEUTICS L.P.
**KLOXXADO® is a registered trademark of Hikma Pharmaceuticals USA Inc.